Explore AstraZeneca's significant investment of C$820 million in Ontario, aimed at expanding its research and development hub. This initiative promises to create over 700 skilled jobs, leverage cutting-edge technologies, and redefine clinical trials to en...

In today’s trading session, AstraZeneca experienced a slight decline of 0.1%, reflecting the complex dynamics of international markets as Swedish stocks fluctuate in North America. With significant trading volumes, this minor drop invites investors to exp...